Remarkably, co-expression of TWIST1 and ZEB2 was correlated with poorer overall survival in OSCC, particularly in patients with no lymph node metastasis (34). The gene discussed is TWIST1; the disease is metastatic malignant neoplasm in the lymph nodes.